[Exocrine pancreatic insufficiency (author's transl)].
Exocrine pancreatic insufficiency usually does not develop before reduction of enzyme output by more than 90%. Patients with pancreatic insufficiency have a ravenous appetite but fail to thrive from malnutrition. The caloric deprivation is primarily due to fat malabsorption, recognized by the passage of bulky foul smelling greasy stools. Several isolated enzyme deficiencies can be separated from diseases with generalised pancreatic insufficiency. Under replacement therapy with pancreatic enzyme supplements most patients improve and gain weight, although fat and bile acid malabsorption are not abolished.
D000592:Amino Acid Metabolism, Inborn Errors / Q000175:diagnosis; D000681:Amylases / Q000172:deficiency; D003550:Cystic Fibrosis / Q000175:diagnosis; D004765:Enteropeptidase / Q000172:deficiency; D057487:Enzyme Therapy; D010188:Exocrine Pancreatic Insufficiency / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007408:Intestinal Absorption; D007732:Kwashiorkor / Q000175:diagnosis; D008049:Lipase / Q000172:deficiency; D050356:Lipid Metabolism; D008286:Malabsorption Syndromes / Q000175:diagnosis; D014362:Trypsinogen / Q000172:deficiency
D014362:Trypsinogen; D008049:Lipase; D000681:Amylases; D004765:Enteropeptidase
Klinik der exokrinen Pankreasinsuffizienz.